# IFM Tre

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ifm-tre

- Industry: Pharmaceuticals
- Headquarters: Boston, US
- Total disclosed funding: $31M
- Latest round: Series A (Jul 19, 2018)
- Investors on record: 3

## About

Based in Massachusetts, US, IFM Tre develops pharmaceutical treatments for inflammatory responses inherent in various diseases.

## Funding rounds

- Series A, Jul 19, 2018, $31M — Abingworth, Atlas Venture, Bristol-Myers Squibb Company

## Investors

- Abingworth (https://capitalatlas.ai/funds/abingworth) — Series A
- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Series A
- Bristol-Myers Squibb Company — Series A